These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10087004)

  • 21. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis.
    Jonassen TE; Nielsen S; Christensen S; Petersen JS
    Am J Physiol; 1998 Aug; 275(2):F216-25. PubMed ID: 9691010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985.
    Decaux G
    J Lab Clin Med; 2001 Jul; 138(1):18-21. PubMed ID: 11433224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal water handling in rats with decompensated liver cirrhosis.
    Jonassen TE; Christensen S; Kwon TH; Langhoff S; Salling N; Nielsen S
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1101-9. PubMed ID: 11097629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of vasopressin receptor antagonist OPC-31260 on experimental brain oedema induced by global cerebral ischaemia.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Acta Neurochir (Wien); 2008 Mar; 150(3):265-71. PubMed ID: 18288441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Gross P; Distler A; Bauer C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S434-5. PubMed ID: 8587436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.
    Serradeil-Le Gal C; Lacour C; Valette G; Garcia G; Foulon L; Galindo G; Bankir L; Pouzet B; Guillon G; Barberis C; Chicot D; Jard S; Vilain P; Garcia C; Marty E; Raufaste D; Brossard G; Nisato D; Maffrand JP; Le Fur G
    J Clin Invest; 1996 Dec; 98(12):2729-38. PubMed ID: 8981918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit?
    Sansoè G; Aragno M; Mastrocola R; Parola M
    Clin Sci (Lond); 2016 Jan; 130(2):117-24. PubMed ID: 26519424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased gene expression of water channel in cirrhotic rat kidneys.
    Asahina Y; Izumi N; Enomoto N; Sasaki S; Fushimi K; Marumo F; Sato C
    Hepatology; 1995 Jan; 21(1):169-73. PubMed ID: 7528708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of chronic octreotide treatment on renal changes during cirrhosis in rats.
    Jonassen TE; Christensen S; Sørensen AM; Marcussen N; Flyvbjerg A; Andreasen F; Petersen JS
    Hepatology; 1999 May; 29(5):1387-95. PubMed ID: 10216120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Ferguson JW; Therapondos G; Newby DE; Hayes PC
    Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of novel vasopressin receptor antagonists on renal function and cardiac hypertrophy in rats with experimental congestive heart failure.
    Bishara B; Shiekh H; Karram T; Rubinstein I; Azzam ZS; Abu-Saleh N; Nitecki S; Winaver J; Hoffman A; Abassi ZA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):414-22. PubMed ID: 18467593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis.
    Camps J; Solá J; Arroyo V; Pérez-Ayuso RM; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1987 Sep; 93(3):498-505. PubMed ID: 3609659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
    López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Altuna R; Arroyo V; Rivera F; Rodés J
    Br J Pharmacol; 2002 Feb; 135(4):891-900. PubMed ID: 11861316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum.
    Dolgor B; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Matsumoto T
    J Surg Res; 1998 Oct; 79(2):109-14. PubMed ID: 9758724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke.
    Guéniau C; Oberlander C
    J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.
    Gunnet JW; Matthews JM; Maryanoff BE; de Garavilla L; Andrade-Gordon P; Damiano B; Hageman W; Look R; Stahle P; Streeter AJ; Wines PG; Demarest KT
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):320-6. PubMed ID: 16620295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of renal adenylate cyclase-coupled vasopressin receptors after chronic administration of vasopressin antagonists to rats.
    Caltabiano S; Kinter LB
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1046-54. PubMed ID: 1832462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.